Association of rpoB mutations with rifampicin resistance in Mycobacterium avium

Benson, 1994, Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome, Clin Infect Dis, 18, S218, 10.1093/clinids/18.Supplement_3.S218

Horsburgh, 1992, Epidemiology of mycobacterial diseases in AIDS, Res Microbiol, 143, 372, 10.1016/0923-2508(92)90048-S

Takahara, 2002, Pulmonary Mycobacterium avium infection in an immunocompetent aged woman related to use of home bath with a circulating water system, Jpn J Infect Dis, 55, 213

Watando, 2001, Pulmonary Mycobacterium avium infection in an immunocompetent young adult related to use of home bath with a circulating water system, Jpn J Infect Dis, 54, 151

Heifets, 1966, Susceptibility testing of Mycobacterium avium complex isolates, Antimicrob Agents Chemother, 40, 1759, 10.1128/AAC.40.8.1759

Guilhot, 1992, Temperature-sensitive mutants of the Mycobacterium plasmid pAL5000, FEMS Microbiol Lett, 77, 181, 10.1111/j.1574-6968.1992.tb05510.x

National Committee for Clinical Laboratory Standards. Susceptibility testing of Mycobacteria, Nocardiae, and other Aerobic Actinomycetes. 2nd ed. Tentative Standard M24-T2. Wayne, PA: NCCLS; 2000.

Hui, 1977, Permeability barrier to rifampin in mycobacteria, Antimicrob Agents Chemother, 11, 773, 10.1128/AAC.11.5.773

Aubry-Damon, 1998, Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus, Antimicrob Agents Chemother, 42, 2590, 10.1128/AAC.42.10.2590

Ovchinnikov, 1983, RNA polymerase rifampicin resistance mutations in Escherichia coli: sequence changes and dominance, Mol Gen Genet, 190, 344, 10.1007/BF00330662

Williams, 1994, Characterization of rifampin-resistance in pathogenic mycobacteria, Antimicrob Agents Chemother, 38, 2380, 10.1128/AAC.38.10.2380

Portillo-Gomez, 1995, The absence of genetic markers for streptomycin and rifampicin resistance in Mycobacterium avium complex strains, J Antimicrob Chemother, 36, 1049, 10.1093/jac/36.6.1049

Musser, 1995, Antimicrobial agent resistance in mycobacteria: molecular genetic insights, Clin Microbiol Rev, 8, 496, 10.1128/CMR.8.4.496

Zhang, 1999, Crystal structure of Thermus aquaticus core RNA polymerase at 3.3Å resolution, Cell, 98, 811, 10.1016/S0092-8674(00)81515-9

Campbell, 2001, Structural mechanism for rifampicin inhibition of bacterial RNA polymerase, Cell, 104, 901, 10.1016/S0092-8674(01)00286-0

McClure, 1978, On the mechanism of rifampicin inhibition of RNA synthesis, J Biol Chem, 253, 8949, 10.1016/S0021-9258(17)34269-2

Telenti, 1993, Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis, Lancet, 341, 647, 10.1016/0140-6736(93)90417-F

Zhang, 2000, Genetics of drug resistance in Mycobacterium tuberculosis

Kremer, 1995, Green fluorescent protein as a new expression marker in mycobacteria, Mol Microbiol, 17, 913, 10.1111/j.1365-2958.1995.mmi_17050913.x

Parish, 1998, Electroporation of mycobacteria

Casali, 2001, Plasmid vectors

Engbaek, 1971, Mycobacterium avium Chester, Int J Syst Bacteriol, 21, 192, 10.1099/00207713-21-2-192

Saito, 1998, Identification and partial characterization of Mycobacterium avium and Mycobacterium intracellulare by using DNA probes, J Clin Microbiol, 27, 994, 10.1128/JCM.27.5.994-997.1989

Piddock, 2000, Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis, J Antimicrob Chemother, 45, 159, 10.1093/jac/45.2.159

Dabbs ER, Yazawa K, Mikami Y, et al. Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation. Antimicrobial Agents Chemother 1995;39:1007–9.